Invention Grant
- Patent Title: Immunostimulatory method
-
Application No.: US16522779Application Date: 2019-07-26
-
Publication No.: US11351114B2Publication Date: 2022-06-07
- Inventor: David Charles Jackson , Amabel Tan , Weiguang Zeng
- Applicant: ENA THERAPEUTICS PTY LTD
- Applicant Address: AU Melbourne
- Assignee: ENA THERAPEUTICS PTY LTD
- Current Assignee: ENA THERAPEUTICS PTY LTD
- Current Assignee Address: AU Melbourne
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: AU2010904284 20100922,AU2011902408 20110620
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/04 ; A61K47/60 ; A61K39/39 ; A61K9/00 ; A61K38/06 ; A61K38/07 ; A61K38/08 ; C07K7/06 ; A61K31/23

Abstract:
This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
Public/Granted literature
- US20190380952A1 NOVEL IMMUNOSTIMULATORY METHOD Public/Granted day:2019-12-19
Information query